101 related articles for article (PubMed ID: 31449053)
1. Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation.
Pan C; Chun J; Li D; Boese AC; Li J; Kang J; Umano A; Jiang Y; Song L; Magliocca KR; Chen ZG; Saba NF; Shin DM; Owonikoko TK; Lonial S; Jin L; Kang S
J Clin Invest; 2019 Oct; 129(10):4110-4123. PubMed ID: 31449053
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9-based genome-wide screening for deubiquitinase subfamily identifies USP1 regulating MAST1-driven cisplatin-resistance in cancer cells.
Tyagi A; Kaushal K; Chandrasekaran AP; Sarodaya N; Das S; Park CH; Hong SH; Kim KS; Ramakrishna S
Theranostics; 2022; 12(13):5949-5970. PubMed ID: 35966591
[No Abstract] [Full Text] [Related]
3. MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation.
Jin L; Chun J; Pan C; Li D; Lin R; Alesi GN; Wang X; Kang HB; Song L; Wang D; Zhang G; Fan J; Boggon TJ; Zhou L; Kowalski J; Qu CK; Steuer CE; Chen GZ; Saba NF; Boise LH; Owonikoko TK; Khuri FR; Magliocca KR; Shin DM; Lonial S; Kang S
Cancer Cell; 2018 Aug; 34(2):315-330.e7. PubMed ID: 30033091
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1.
Pan C; Kang J; Hwang JS; Li J; Boese AC; Wang X; Yang L; Boggon TJ; Chen GZ; Saba NF; Shin DM; Magliocca KR; Jin L; Kang S
Nat Commun; 2021 Aug; 12(1):4960. PubMed ID: 34400618
[TBL] [Abstract][Full Text] [Related]
5. USP28 promotes tumorigenesis and cisplatin resistance by deubiquitinating MAST1 protein in cancer cells.
Karapurkar JK; Colaco JC; Suresh B; Tyagi A; Woo SH; Jo WJ; Ko N; Singh V; Hong SH; Oh SJ; Kim KS; Ramakrishna S
Cell Mol Life Sci; 2024 Mar; 81(1):145. PubMed ID: 38498222
[TBL] [Abstract][Full Text] [Related]
6. MAST1 modulates neuronal differentiation and cell cycle exit via P27 in neuroblastoma cells.
Jing T; Ma J; Zhao H; Zhang J; Jiang N; Ma D
FEBS Open Bio; 2020 Jun; 10(6):1104-1114. PubMed ID: 32291963
[TBL] [Abstract][Full Text] [Related]
7. Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation.
Wu AY; Gu LY; Cang W; Cheng MX; Wang WJ; Di W; Huang L; Qiu LH
J Exp Clin Cancer Res; 2019 Apr; 38(1):176. PubMed ID: 31023317
[TBL] [Abstract][Full Text] [Related]
8. Mast1 mediates radiation-induced gastric injury via the P38 MAPK pathway.
Ding W; Lu Y; Zhou A; Chen Y; Wang Z; Wang L; Tian Y
Exp Cell Res; 2021 Dec; 409(2):112913. PubMed ID: 34774870
[TBL] [Abstract][Full Text] [Related]
9. E3 Ubiquitin Ligase CHIP Inhibits the Interaction between Hsp90
Tan B; Zhang J; Wang W; Ma H; Yang Y
Stem Cells Int; 2022; 2022():2760899. PubMed ID: 36199626
[TBL] [Abstract][Full Text] [Related]
10. Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance.
Yu L; Gu C; Zhong D; Shi L; Kong Y; Zhou Z; Liu S
Cancer Lett; 2014 Dec; 355(1):34-45. PubMed ID: 25236911
[TBL] [Abstract][Full Text] [Related]
11. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity.
Paul I; Ahmed SF; Bhowmik A; Deb S; Ghosh MK
Oncogene; 2013 Mar; 32(10):1284-95. PubMed ID: 22543587
[TBL] [Abstract][Full Text] [Related]
12. Hsp90 rescues PTK6 from proteasomal degradation in breast cancer cells.
Kang SA; Cho HS; Yoon JB; Chung IK; Lee ST
Biochem J; 2012 Oct; 447(2):313-20. PubMed ID: 22849407
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 90 functions to stabilize and activate the testis-specific serine/threonine kinases, a family of kinases essential for male fertility.
Jha KN; Coleman AR; Wong L; Salicioni AM; Howcroft E; Johnson GR
J Biol Chem; 2013 Jun; 288(23):16308-16320. PubMed ID: 23599433
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of integrin-linked kinase by the Hsp90-CHIP axis impacts cellular force generation, migration and the fibrotic response.
Radovanac K; Morgner J; Schulz JN; Blumbach K; Patterson C; Geiger T; Mann M; Krieg T; Eckes B; Fässler R; Wickström SA
EMBO J; 2013 May; 32(10):1409-24. PubMed ID: 23612611
[TBL] [Abstract][Full Text] [Related]
15. Pim-1 kinase stability is regulated by heat shock proteins and the ubiquitin-proteasome pathway.
Shay KP; Wang Z; Xing PX; McKenzie IF; Magnuson NS
Mol Cancer Res; 2005 Mar; 3(3):170-81. PubMed ID: 15798097
[TBL] [Abstract][Full Text] [Related]
16. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
[TBL] [Abstract][Full Text] [Related]
17. PGK1 facilities cisplatin chemoresistance by triggering HSP90/ERK pathway mediated DNA repair and methylation in endometrial endometrioid adenocarcinoma.
Zhou JW; Tang JJ; Sun W; Wang H
Mol Med; 2019 Mar; 25(1):11. PubMed ID: 30925862
[TBL] [Abstract][Full Text] [Related]
18. Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance.
Pan C; Jin L; Wang X; Li Y; Chun J; Boese AC; Li D; Kang HB; Zhang G; Zhou L; Chen GZ; Saba NF; Shin DM; Magliocca KR; Owonikoko TK; Mao H; Lonial S; Kang S
J Clin Invest; 2019 May; 129(6):2431-2445. PubMed ID: 31081803
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of mammalian sterile 20-like kinase 1 by heat shock protein 70 mediates cisplatin resistance in prostate cancer cells.
Ren A; Yan G; You B; Sun J
Cancer Res; 2008 Apr; 68(7):2266-74. PubMed ID: 18381433
[TBL] [Abstract][Full Text] [Related]
20. Hsp90 inhibition renders iNOS aggregation and the clearance of iNOS aggregates by proteasomes requires SPSB2.
Wang T; Luo S; Qin H; Xia Y
Free Radic Biol Med; 2018 Mar; 117():90-98. PubMed ID: 29367003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
